Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,750 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
Thiele H, Schuler G, Neumann FJ, Hausleiter J, Olbrich HG, Schwarz B, Hennersdorf M, Empen K, Fuernau G, Desch S, de Waha S, Eitel I, Hambrecht R, Böhm M, Kurowski V, Lauer B, Minden HH, Figulla HR, Braun-Dullaeus RC, Strasser RH, Rochor K, Maier SK, Möllmann H, Schneider S, Ebelt H, Werdan K, Zeymer U. Thiele H, et al. Among authors: schneider s. Am Heart J. 2012 Jun;163(6):938-45. doi: 10.1016/j.ahj.2012.03.012. Am Heart J. 2012. PMID: 22709745 Clinical Trial.
Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction Registry.
Zahn R, Schiele R, Schneider S, Gitt AK, Seidl K, Bossaller C, Schuler G, Gottwik M, Altmann E, Rosahl W, Senges J. Zahn R, et al. Among authors: schneider s. Am J Cardiol. 2001 Jan 1;87(1):1-6. doi: 10.1016/s0002-9149(00)01262-5. Am J Cardiol. 2001. PMID: 11137824 Clinical Trial.
Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: results from the MITRA and MIR studies.
Frilling B, Schiele R, Gitt AK, Zahn R, Schneider S, Glunz HG, Gieseler U, Baumgärtel B, Asbeck F, Senges J; Maximum Individual Therapy in Acute Myocardial Infarction (MITRA); Myocardial Infarction Registry (MIR) Study Groups. Frilling B, et al. Among authors: schneider s. Am Heart J. 2001 Feb;141(2):200-5. doi: 10.1067/mhj.2001.112681. Am Heart J. 2001. PMID: 11174332
Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis.
Zahn R, Schiele R, Gitt AK, Schneider S, Seidl K, Voigtländer T, Gottwik M, Altmann E, Gieseler U, Rosahl W, Wagner S, Senges J; Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group; Myocardial Infarction Registry Study Group. Zahn R, et al. Among authors: schneider s. Am Heart J. 2001 Jul;142(1):105-11. doi: 10.1067/mhj.2001.115585. Am Heart J. 2001. PMID: 11431665 Clinical Trial.
[Too many heart catheter procedures in Germany ?].
Gottwik M, Zeymer U, Schneider S, Senges J. Gottwik M, et al. Among authors: schneider s. Dtsch Med Wochenschr. 2003 Oct 10;128(41):2121-4. doi: 10.1055/s-2003-42863. Dtsch Med Wochenschr. 2003. PMID: 14534860 German.
Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.
Frilling B, Schiele R, Gitt AK, Zahn R, Schneider S, Glunz HG, Gieseler U, Jagodzinski E, Senges J; Maximal Individual Therapy in Acute Myocardial Infarction Study Group. Frilling B, et al. Among authors: schneider s. Am Heart J. 2004 Aug;148(2):306-11. doi: 10.1016/j.ahj.2004.01.027. Am Heart J. 2004. PMID: 15309001
Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial.
Zeymer U, Zahn R, Schiele R, Jansen W, Girth E, Gitt A, Seidl K, Schröder R, Schneider S, Senges J. Zeymer U, et al. Among authors: schneider s. Eur Heart J. 2005 Oct;26(19):1971-7. doi: 10.1093/eurheartj/ehi293. Epub 2005 Apr 27. Eur Heart J. 2005. PMID: 15857851 Clinical Trial.
Incidence and predictors of target vessel revascularization and clinical event rates of the sirolimus-eluting coronary stent (results from the prospective multicenter German Cypher Stent Registry).
Zahn R, Hamm CW, Schneider S, Zeymer U, Nienaber CA, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Senges J; German Cypher Stent Registry. Zahn R, et al. Among authors: schneider s. Am J Cardiol. 2005 Jun 1;95(11):1302-8. doi: 10.1016/j.amjcard.2005.01.072. Am J Cardiol. 2005. PMID: 15904633
Predictors of death or myocardial infarction during follow-up after coronary stenting with the sirolimus-eluting stent. Results from the prospective multicenter German Cypher Stent Registry.
Zahn R, Hamm CW, Schneider S, Zeymer U, Richardt G, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Nienaber CA, Senges J; German Cypher Stent Registry. Zahn R, et al. Among authors: schneider s. Am Heart J. 2006 Dec;152(6):1146-52. doi: 10.1016/j.ahj.2006.07.011. Am Heart J. 2006. PMID: 17161068
4,750 results